Superworth

Gossamer Bio EPS GOSS

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
−$55.20
Latest quarter, Q2 FY26
−$6.40
Fiscal year 2025
−$59.20

Gossamer Bio's earnings per share was −$55.20 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$6.40.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$59.20n/a
FY2024−$20.80n/a
FY2023−$111.20n/a
FY2022−$219.20n/a
FY2021−$249.60n/a
FY2020−$284.00n/a
FY2019−$266.40n/a
FY2018−$1834.40n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$6.40n/a−$55.20
Q1 FY26−$16.00n/a−$62.40
Q4 FY25−$16.00n/a−$59.20
Q3 FY25−$16.80n/a−$55.20
Q2 FY25−$13.60−177%−$49.60
Q1 FY25−$12.80n/a−$18.40
Q4 FY24−$12.00n/a−$20.80
Q3 FY24−$11.20n/a−$25.60
Q2 FY24$17.60n/a−$31.20
Q1 FY24−$15.20n/a−$84.80
Q4 FY23−$16.80n/a−$111.20
Q3 FY23−$16.80n/a−$141.60

Against its peers

Companies in Drug Manufacturers - General nearest Gossamer Bio's size, closest first, today.

CompanyEPS, 12 monthsGrowth
GOSSGossamer Bio−$55.20
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
Peer median$0.46

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Gossamer Bio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.